entertainment -WSS

entertainment

author：knowledge 2025-09-27 12:55:12 - browse：66449

If you ask a chatbot how to cause a pandemic, it will suggest the 1918 influenza virus, according to researcher Kevin Esvelt. It will even tell you where to find the gene sequences online and where to purchase the genetic components.

Esvelt is a biologist and MIT professor whose work has included altering the genes of mice to prevent the spread of Lyme disease. In a recent First Opinion essay, he wrote about how easy and inexpensive it has become to order genetic components that could be used to create harmful pathogens or toxins and how the biotech industry and government agencies must strengthen safety precautions to prevent this.

Esvelt sat down with host Pat Skerrett to chat about the amazing things genetic technology can accomplish when used correctly, as well as the dangers of such technology in the hands of someone with bad intentions.

“We’re trying to do biotech to accomplish amazing things and heal people,” Esvelt said. “You don’t want to think about the same tools being misused and, to most scientists, this doesn’t come naturally.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Newsletters

Sign up for First Opinion Podcast

Weekly alerts when a new episode drops from STAT’s First Opinion podcast

Please enter a valid email address. Privacy Policy

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： New weight loss drugs vying to be the next Wegovy or Mounjaro

WSS

'Essentially witchcraft:' A former naturopath takes on the field

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Walmart eyes Medicare Advantage provider ChenMed

5 takeaways from STAT's examination of Zynex Medical

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

A common UTI test for kids haunts adults as a traumatic 'nightmare'

explore

entertainment

Sign up for First Opinion Podcast

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Hepatitis C has a cure — but many Americans still lack access to it

FDA proposes changes to key medical devices approval pathway

Hepatitis C has a cure — but many Americans still lack access to it

Regeneron agrees to White House price limits on anti

Novavax promises a turnaround & Lilly roils the obesity market

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

In age of alternative facts, a scholarly course on calling out crap

How medical schools plan to diversify without affirmative action

focus

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Long Covid needs a new name — and a new frame

Cigna wins case to block Amy Bricker's move to CVS

Pharma companies must ensure equitable access to obesity drugs

My daughter's legacy lives on through her writing, phage therapy

Cheap, fast test for Zika and dengue could cost just $1

focus

knowledge

focus

leisure time